Cargando…

Overcoming the Blues: Can Managing Depressive Symptoms Improve Access to Kidney Transplantation?

Detalles Bibliográficos
Autores principales:	Plantinga, Laura C., Penmatsa, Krishnam Raju, Urbanski, Megan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174031/ https://www.ncbi.nlm.nih.gov/pubmed/35694564 http://dx.doi.org/10.1016/j.ekir.2022.04.015

Ejemplares similares

Best-Laid Plans: Can a “Life-Plan” Improve the Concordance of Kidney Disease Care with Patient Preferences?
por: Urbanski, Megan, et al.
Publicado: (2023)

Depressive Symptoms at Kidney Transplant Evaluation and Access to the Kidney Transplant Waitlist
por: Chen, Xiaomeng, et al.
Publicado: (2022)

Gender Disparities in Access to Kidney Transplant: Inequities in the Inequity
por: Vinson, Amanda J.
Publicado: (2022)

Ileal mucormycosis: a rare cause of lower gastrointestinal bleeding
por: Shetty, Shiran, et al.
Publicado: (2014)

Geographic Differences in Racial Disparities in Access to Kidney Transplantation
por: McPherson, Laura J., et al.
Publicado: (2023)

Current practice with grafts with multiple renal arteries in kidney transplantation: role of the methylene blue in the lower pole
por: Cherchi, Vittorio, et al.
Publicado: (2022)

Patients with kidney failure who cannot access dialysis in rural and remote areas of Canada should be prioritized for kidney transplantation
por: Trachtenberg, Aaron J., et al.
Publicado: (2021)

Masked Hypertension: Lessons for the Future
por: Penmatsa, Krishnam R, et al.
Publicado: (2020)

Challenges in stem cell-derived islet replacement therapy can be overcome
por: Abdulreda, Midhat H., et al.
Publicado: (2021)

Medicare immunosuppressant coverage and access to kidney transplantation: a retrospective national cohort study
por: Grubbs, Vanessa, et al.
Publicado: (2012)

Can Thyroid Hormone Analogues Be Used to Overcome Hypomyelination and Demyelination of the Central Nervous System?
por: Cullen, Carlie L., et al.
Publicado: (2017)

Rhabdomyolysis: Revisited
por: Gupta, Ankur, et al.
Publicado: (2021)

Revascularization of Transplanted Islets: Can It Be Improved?
por: Brissova, Marcela, et al.
Publicado: (2008)

Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?
por: Malvezzi, Paolo, et al.
Publicado: (2018)

Benefits of Kidney Transplantation or Living Donation?
por: Gaillard, François
Publicado: (2020)

A Kidney International “journal of the COVID-19 year” in kidney transplantation
por: Coates, P. Toby
Publicado: (2020)

How Blue is the Sky?
por: Frégnac, Yves
Publicado: (2021)

Can depression be a menopause-associated risk?
por: Soares, Claudio N
Publicado: (2010)

Schizophrenia, Depressive Symptoms, and Antipsychotic Drug Treatment
por: Reynolds, Gavin P, et al.
Publicado: (2021)

Can you justify not using ultrasound guidance for central venous access?
por: Bodenham, Andrew R
Publicado: (2006)

The RaDIANT community study protocol: community-based participatory research for reducing disparities in access to kidney transplantation
por: Patzer, Rachel E, et al.
Publicado: (2014)

Kidney Transplantation in Septuagenarians: 70 Is the New 60!
por: Hebert, Sean A., et al.
Publicado: (2019)

Overcoming physical barriers in cancer therapy
por: Beyer, Ines, et al.
Publicado: (2013)

Interchangeability of Biosimilars: Overcoming the Final Hurdles
por: Barbier, Liese, et al.
Publicado: (2021)

How Can We Predict Treatment Outcome for Depression?
por: Walter, Martin, et al.
Publicado: (2014)

Commentary on transplant outcomes of 100 cases of living-donor ABO-incompatible kidney transplantation
por: Ishida, Hideki
Publicado: (2022)

The quest for universal access to effective malaria treatment: how can the AMFm contribute?
por: Matowe, Lloyd, et al.
Publicado: (2010)

Understanding and Overcoming Barriers to Medication Adherence: A Review of Research Priorities
por: Seabury, Seth A., et al.
Publicado: (2014)

Long-term Use of Eculizumab in Kidney Transplant Recipients
por: Milan Manani, Sabrina, et al.
Publicado: (2018)

Post-Transplant Hypotension in Kidney Recipients—Vasopressin to the Rescue?
por: Bajpai, Divya, et al.
Publicado: (2022)

MAP4K1 expression is a novel resistance mechanism and independent prognostic marker in AML-but can be overcome via targeted inhibition
por: Knight, Tristan E., et al.
Publicado: (2021)

White collar rhabdomyolysis with acute kidney injury
por: Bhakthavatsalam, R. K., et al.
Publicado: (2016)

How food in the commons can help to address inequity in US food and land access
por: Anderson, Molly D.
Publicado: (2021)

PKCδ Blues for the β-Cell
por: Schmitz-Peiffer, Carsten, et al.
Publicado: (2010)

Interleukin receptor antagonist induction in kidney transplantation: Is it worth the price?
por: Kher, V.
Publicado: (2013)

Urinary metabolites give new clues to kidney transplant tolerance
por: Mooney, Nuala
Publicado: (2022)

Identifying Drivers of Poor Kidney Transplant Outcomes in Indigenous Populations
por: Hall, Isaac E., et al.
Publicado: (2022)

Is Hyperparathyroidism a Concern for Allograft Dysfunction in Pediatric Kidney Transplantation?
por: Kaul, Sheena, et al.
Publicado: (2022)

Exploring the uncharted territory of social media: the next frontier of medical education in nephrology
por: Desai, Tejas, et al.
Publicado: (2018)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_av9etqqeqs5c9ggboplp9vi1qp